102 related articles for article (PubMed ID: 1848652)
21. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.
Bidlack JM; Frey DK; Kaplan RA; Seyed-Mozaffari A; Archer S
Mol Pharmacol; 1990 Jan; 37(1):50-9. PubMed ID: 1688995
[TBL] [Abstract][Full Text] [Related]
22. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
23. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM
NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
[TBL] [Abstract][Full Text] [Related]
24. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
25. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
26. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
Michel ME; Bolger G; Weissman BA
Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
[TBL] [Abstract][Full Text] [Related]
27. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
James IF; Goldstein A
Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
[TBL] [Abstract][Full Text] [Related]
28. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
29. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
30. Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine.
Bidlack JM; Kaplan RA; Subbramanian RA; Seyed-Mozaffari A; Archer S
Biochemistry; 1993 Jul; 32(26):6703-11. PubMed ID: 7687147
[TBL] [Abstract][Full Text] [Related]
31. [3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.
Schnittler M; Liebmann C; Schrader U; Schulze HP; Neubert K; Repke H
Biomed Biochim Acta; 1990; 49(4):209-18. PubMed ID: 2169723
[TBL] [Abstract][Full Text] [Related]
32. Electron microscopic localization of photoaffinity-labelled delta opioid receptors in the neostriatum of the rat.
Pasquini F; Bochet P; Garbay-Jaureguiberry C; Roques BP; Rossier J; Beaudet A
J Comp Neurol; 1992 Dec; 326(2):229-44. PubMed ID: 1336020
[TBL] [Abstract][Full Text] [Related]
33. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
Tao PL; Law PY; Loh HH
J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
[TBL] [Abstract][Full Text] [Related]
34. A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors.
Mejean A; Hawkinson J; Guthapfel R; Goeldner M; Hirth C
Biochemistry; 1992 Oct; 31(40):9685-93. PubMed ID: 1327126
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of substituted benzoylhydrazones of naloxone.
Ciszewska GR; Ginos JA; Charton M; Standifer KM; Brooks AI; Brown GP; Ryan-Moro JP; Berzetei-Gurske I; Toll L; Pasternak GW
Synapse; 1996 Oct; 24(2):193-201. PubMed ID: 8890461
[TBL] [Abstract][Full Text] [Related]
36. Enhanced affinity of opiate receptors for naloxone in striatal slices of morphine-dependent mice.
Kitano T; Takemori AE
Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):341-51. PubMed ID: 199923
[TBL] [Abstract][Full Text] [Related]
37. Effect of sodium ion on the affinity of naloxone for the kappa opioid receptor.
Cheney BV; Lahti RA
Life Sci; 1987 Mar; 40(11):1071-4. PubMed ID: 3029528
[TBL] [Abstract][Full Text] [Related]
38. Kappa 3 opiate receptor binding in the mouse and rat.
Cheng J; Roques BP; Gacel GA; Huang E; Pasternak GW
Eur J Pharmacol; 1992 May; 226(1):15-20. PubMed ID: 1327838
[TBL] [Abstract][Full Text] [Related]
39. Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs.
Shirasu N; Kuromizu T; Nakao H; Chuman Y; Nose T; Costa T; Shimohigashi Y
J Biochem; 1999 Jul; 126(1):254-9. PubMed ID: 10393346
[TBL] [Abstract][Full Text] [Related]
40. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells.
Mathis JP; Mandyam CD; Altememi GF; Pasternak GW; Standifer KM
Neurosci Lett; 2001 Feb; 299(3):173-6. PubMed ID: 11165763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
